Does ESKETAMINE Cause Neoplasm malignant? 67 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Neoplasm malignant have been filed in association with ESKETAMINE (Spravato). This represents 0.4% of all adverse event reports for ESKETAMINE.
67
Reports of Neoplasm malignant with ESKETAMINE
0.4%
of all ESKETAMINE reports
5
Deaths
7
Hospitalizations
How Dangerous Is Neoplasm malignant From ESKETAMINE?
Of the 67 reports, 5 (7.5%) resulted in death, 7 (10.4%) required hospitalization, and 6 (9.0%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESKETAMINE. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does ESKETAMINE Cause?
Dissociation (3,103)
Sedation (2,244)
Suicidal ideation (1,254)
Drug ineffective (1,005)
Nausea (807)
Depression (800)
Anxiety (659)
Hospitalisation (657)
Product dose omission issue (635)
Hypertension (605)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ESKETAMINE Alternatives Have Lower Neoplasm malignant Risk?
ESKETAMINE vs ESLICARBAZEPINE
ESKETAMINE vs ESMOLOL
ESKETAMINE vs ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\NAPROXEN